What is your opinion on Alembic Pharmaceuticals Ltd. wait or accumulate.

Ans: not very expensive ! promoters have been a bit tricky in the past, otherwise a good company !

Ans: Growth in Net Profit with increasing Profit Margin (QoQ)
Company with Low Debt
Company with Zero Promoter Pledge
FII / FPI or Institutions increasing their shareholding
Data is good the only concern is Annual net profit declining for last 2 years. FII's have reduced the holdings but Mutual Funds have increased in the last quarter. Don't accumulate at this level, it can come around 560 which is good level to accumulate.

Disclaimer: Investments in securities are subject to market RISKS. Read all the related documents carefully before investing. The securities quoted are for illustration only and are not recommendatory. Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Ans: Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
2 negative things but some improvement through Growth in Net Profit with increasing Profit Margin (QoQ) so HOLD it for atleast 2 years.

Disclaimer: Investments in securities are subject to market RISKS. Read all the related documents carefully before investing. The securities quoted are for illustration only and are not recommendatory. Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Ans: Decline in Quarterly Net Profit with falling Profit Margin (YoY) and weak financials. This needs to be changed, check this quarterly results and then take action accordingly.

Disclaimer: Investments in securities are subject to market RISKS. Read all the related documents carefully before investing. Please consult your appointed/paid financial adviser before taking any decision. The securities quoted are for illustration only and are not recommendatory. Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.